Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
AVT heads into its October 28 earnings date with short sellers gradually retreating, options traders staying relaxed, and a stock that has more than doubled year-to-date now pulling back modestly from recent highs.
Short interest on Avnet has been grinding lower for the past two weeks. It now stands at 10.2% of the free float, down about 2.4% on the week and off from a brief spike near 11.5% seen on September 9. That spike looks like a one-day anomaly: shares short jumped to 9.6 million before reverting quickly to the 8.3 to 8.5 million range where they have settled ever since. At 10.2%, short interest is elevated in absolute terms but trending in the wrong direction for bears, with the ORTEX short score easing to 53.8 from above 55 just two weeks ago. The borrow market is notably relaxed: availability has loosened sharply over the past week to 2,732%, meaning the lending pool is far from stressed. Cost to borrow has nearly doubled over the past week to 0.62%, but from such a low base that even after the move it registers as cheap by any measure.
Options positioning adds little urgency to the story. The put/call ratio has drifted slightly above its 20-day average, now at 0.44 compared to a mean of 0.38, giving a z-score of just 0.69. That is a mild tilt toward hedging rather than a pronounced defensive posture. The 52-week range on the PCR runs from 0.03 to 1.13, so the current reading is comfortably mid-range. Taken together, the short and options data tell a story of investors who are watchful but not particularly anxious ahead of the print.
The Street is more divided. Truist Securities lifted its target to $110 in August and carries a Buy, while Wells Fargo has maintained an Underweight throughout the year with a $72 target, almost a third below where the stock currently trades at $102.53. BofA upgraded from Underperform to Neutral back in May, raising its target to $96. The mean analyst target of $106.25 implies modest upside from here, and with analyst data now almost two months old, the picture may have evolved ahead of the October print. Valuation multiples put context around the split: the stock trades on a PE of around 9.4x and EV/EBITDA of 7.4x, the latter down about 0.18 turns over 30 days as the stock has drifted. The 90th-percentile reading on 90-day EPS momentum is a genuine bright spot, suggesting forward estimates have been moving sharply higher even as some analysts remain on the sidelines.
One data point worth noting is retail attention. Wikipedia views for Avnet show a z-score of 2.24, well above the company's own 90-day history of attention, as of September 21. That is an attention signal, not a revenue indicator, but it does suggest the stock has attracted more casual investor interest than usual during its remarkable run.
The insider register is cleaner than it looks at first glance. The September 14 activity was a cluster of award grants to the CEO, CFO, and several senior vice presidents, compensation mechanics rather than open-market conviction buys. The CFO then sold 6,844 shares on September 15 at $92.75 for around $635,000, and the SVP and CIO sold 13,000 shares on September 16 at $93.71 for roughly $1.2 million. Neither sale was flagged under a 10b5-1 plan, and on a 90-day net basis insiders have disposed of approximately $8 million in shares. With the stock now trading a full 10% above those sale prices, the insider selling looks either well-timed or opportunistic, and either way it is worth carrying into the earnings read.
AVT gained 2.6% on the week but slid 3.6% on Wednesday, moving broadly in line with close peers: ARW fell 3.5% on the day, LFUS dropped 4.3%, and KEYS lost 1.7%, suggesting sector-wide pressure rather than an AVT-specific story. With earnings confirmed for October 28, the central question over the next three weeks is whether the forward estimate upgrades embedded in that 90th-percentile EPS momentum score translate into a beat, and how the company frames the demand environment for electronic components into 2027.
See the live data behind this article on ORTEX.
Open AVT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
